News

MB Therapeutics welcomes its responsible pharmacist and CQO to strengthen its production of GMP-certified pharmaceutical inks.

MB Therapeutics has settled into its new premises. New address, same tight-knit team, and even more energy!

From Rotterdam to Lyon… The MB Therapeutics team took part in key events where pharmaceutical innovation was at the heart of the discussions.

MB Therapeutics raises €2 million to industrialize and launch a solution for the manufacturing of personalized medicines in pharmacies.

A year ago, MB Therapeutics began its journey with a clear mission: to provide innovative solutions in the field of healthcare.

Who better than Damien Stefanelli as COO to lead the MB project and optimize our GMP-certified pharmaceutical operations?

Our team will be at GERPAC 2024 to showcase our innovations in 3D printing for personalized medicine. Come meet us!

Find the interview of Sébastien Gallice, president of PREF and pharmacist in one of the largest preparatory pharmacies in France.

The Public Investment Bank grants MB Therapeutics a subsidy for the development of next-generation drugs.

Discover how Léna Lemierre, an expert in pharmaceutical 3D printing, is accelerating the development of personalized medicine.